miRecule Inc. closes $5.7M to create breakthrough RNA therapies for cancer & muscular dystrophy

May 27, 2021 | Archived

Read the full story here: Global News...

miRecule published in Clinical Cancer Research

Dec 16, 2020 | Archived

Integrated genomic and functional microRNA analysis identifies miR-30-5p as a tumor suppressor and potential therapeutic nanomedicine in head and neck cancer – Clinical Cancer Research

miRecule featured by the BioHealth Capital Region Investment Conference

Dec 16, 2020 | Archived

miRecule closes Seed Round at the second annual BioHealth Capital Region Investment Conference  – BioBuzz

miRecule featured by the FSHD Society

Dec 16, 2020 | Archived

miRecule, Inc., is developing a novel treatment for FSHD – FSHD Society

miRecule awarded grant by Friends of FSH Research

Dec 16, 2020 | Archived

Antisense Oligonucleotide-Antibody Conjugates to Treat FSHD – Friends of FSH Research